Deficiency of Heme Oxygenase-1 Impairs Renal Hemodynamics and Exaggerates Systemic Inflammatory Responses to Renal Ischemia

Overview

Journal Kidney Int

Publisher Elsevier

Specialty Nephrology

Date 2007 Aug 31

PMID 17728706

Citations 57

Authors

M J Tracz

J P Juncos

A J Croatt

A W Ackerman

J P Grande

K L Knutson

G C Kane

A Terzic

M D Griffin

K A Nath

Affiliations

Soon will be listed here.

Abstract

Heme oxygenase-1 may exert cytoprotective effects. In this study we examined the sensitivity of heme oxygenase-1 knockout (HO-1(-/-)) mice to renal ischemia by assessing glomerular filtration rate (GFR) and cytokine expression in the kidney, and inflammatory responses in the systemic circulation and in vital extrarenal organs. Four hours after renal ischemia, the GFR of HO-1(-/-) mice was much lower than that of wild-type mice in the absence of changes in renal blood flow or cardiac output. Eight hours after renal ischemia, there was a marked induction of interleukin-6 (IL-6) mRNA and its downstream signaling effector, phosphorylated signal transducer and activator of transcription 3 (pSTAT3), in the kidney, lung, and heart in HO-1(-/-) mice. Systemic levels of IL-6 were markedly and uniquely increased in HO-1(-/-) mice after ischemia as compared to wild-type mice. The administration of an antibody to IL-6 protected against the renal dysfunction and mortality observed in HO-1(-/-) mice following ischemia. We suggest that the exaggerated production of IL-6, occurring regionally and systemically following localized renal ischemia, in an HO-1-deficient state may underlie the heightened sensitivity observed in this setting.

Citing Articles

The roles of heme oxygenase-1 in renal disease.

Zhai H, Ni L, Wu X Front Nephrol. 2023; 3:1156346.

PMID: 37675385 PMC: 10479750. DOI: 10.3389/fneph.2023.1156346.

The Sigma-1 Receptor Is a Novel Target for Improving Cold Preservation in Rodent Kidney Transplants.

Hosszu A, Toth A, Lakat T, Stepanova G, Antal Z, Wagner L Int J Mol Sci. 2023; 24(14).

PMID: 37511389 PMC: 10380852. DOI: 10.3390/ijms241411630.

Impaired microvascular circulation in distant organs following renal ischemia.

Dominguez J, Xie D, Kelly K PLoS One. 2023; 18(6):e0286543.

PMID: 37267281 PMC: 10237479. DOI: 10.1371/journal.pone.0286543.

Oxypurinol protects renal ischemia/reperfusion injury heme oxygenase-1 induction.

Kang H, Lim C, Kim J, Han S Front Med (Lausanne). 2023; 10:1030577.

PMID: 36968831 PMC: 10033620. DOI: 10.3389/fmed.2023.1030577.

Repeated Episodes of Ischemia/Reperfusion Induce Heme-Oxygenase-1 (HO-1) and Anti-Inflammatory Responses and Protects against Chronic Kidney Disease.

Ortega-Trejo J, Perez-Villalva R, Sanchez-Navarro A, Marquina B, Rodriguez-Iturbe B, Bobadilla N Int J Mol Sci. 2022; 23(23).

PMID: 36498913 PMC: 9739146. DOI: 10.3390/ijms232314573.

References

KRAMER A, POSTLER G, Salhab K, Mendez C, Carey L, Rabb H . Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int. 1999; 55(6):2362-7. DOI: 10.1046/j.1523-1755.1999.00460.x. View

Kane G, Behfar A, Yamada S, Perez-Terzic C, OCochlain F, Reyes S . ATP-sensitive K+ channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes. 2004; 53 Suppl 3:S169-75. DOI: 10.2337/diabetes.53.suppl_3.s169. View

Patel N, Chatterjee P, Di Paola R, Mazzon E, Britti D, De Sarro A . Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther. 2004; 312(3):1170-8. DOI: 10.1124/jpet.104.078659. View

Stenvinkel P, Ketteler M, Johnson R, Lindholm B, Pecoits-Filho R, Riella M . IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int. 2005; 67(4):1216-33. DOI: 10.1111/j.1523-1755.2005.00200.x. View

Nath K, Grande J, Croatt A, Frank E, Caplice N, Hebbel R . Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol. 2005; 166(4):963-72. PMC: 1602372. DOI: 10.1016/S0002-9440(10)62318-8. View

Abraham N, Kappas A . Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med. 2005; 39(1):1-25. DOI: 10.1016/j.freeradbiomed.2005.03.010. View

Zager R, Johnson A, Hanson S, Lund S . Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release. Am J Physiol Renal Physiol. 2005; 289(2):F289-97. DOI: 10.1152/ajprenal.00023.2005. View

Ricchetti G, Williams L, Foxwell B . Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol. 2004; 76(3):719-26. DOI: 10.1189/jlb.0104046. View

Nath K . Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 2006; 70(3):432-43. DOI: 10.1038/sj.ki.5001565. View

10.

Kane G, Behfar A, Dyer R, OCochlain D, Liu X, Hodgson D . KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum Mol Genet. 2006; 15(15):2285-97. DOI: 10.1093/hmg/ddl154. View

11.

Juncos J, Grande J, Murali N, Croatt A, Juncos L, Hebbel R . Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease. Am J Pathol. 2006; 169(1):21-31. PMC: 1698751. DOI: 10.2353/ajpath.2006.051195. View

12.

Li L, Okusa M . Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat Clin Pract Nephrol. 2006; 2(8):432-44. DOI: 10.1038/ncpneph0238. View

13.

Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y . Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med. 2001; 28(3):809-17. DOI: 10.1097/00003246-200003000-00033. View

14.

Agarwal A, Nick H . Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol. 2000; 11(5):965-973. DOI: 10.1681/ASN.V115965. View

15.

Ohta K, Yachie A, Fujimoto K, Kaneda H, Wada T, Toma T . Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis. 2000; 35(5):863-70. DOI: 10.1016/s0272-6386(00)70256-3. View

16.

Nath K, Haggard J, Croatt A, Grande J, Poss K, Alam J . The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol. 2000; 156(5):1527-35. PMC: 1876926. DOI: 10.1016/S0002-9440(10)65024-9. View

17.

Shiraishi F, Curtis L, Truong L, Poss K, Visner G, Madsen K . Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol. 2000; 278(5):F726-36. DOI: 10.1152/ajprenal.2000.278.5.F726. View

18.

Nath K, Vercellotti G, Grande J, Miyoshi H, Paya C, Manivel J . Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int. 2001; 59(1):106-17. DOI: 10.1046/j.1523-1755.2001.00471.x. View

19.

Kanwar Y . Heme oxygenase-1 in renal injury: conclusions of studies in humans and animal models. Kidney Int. 2001; 59(1):378-9. DOI: 10.1046/j.1523-1755.2001.00505.x. View

20.

Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt S . Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int. 2001; 60(6):2118-28. DOI: 10.1046/j.1523-1755.2001.00043.x. View